メインコンテンツにスキップ
ホーム / コンテンツ / オンデマンド・ウェビナー / Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

20200428
録画ウェビナー
YouTube video

COVID-19 has the potential to negatively impact critical activities such as patient recruitment, patient safety and ensuring data integrity. Thus, clinical developers should review their planned regulatory filing strategies to determine if modifications are required. Attend this webinar to learn mitigation strategies and best practices that you can begin implementing now.

講演者
Demetrius Carter, SVP Services Operations & Regulatory Services
Elaine B. Taylor, VP, Regulatory Strategy and Policy

Powered by Translations.com GlobalLink OneLink Software